For decades, we've been told “Lower LDL is Better.” But what if, in our myopic obsession with LDL and ApoB, we’ve missed a ...

As clinicians, we know that lowering low-density lipoprotein cholesterol (LDL-C) with statins alone or in combination with nonstatin therapies such as a proprotein convertase subtilisin/kexin type 9 ...

Cholesterol is often discussed as good versus bad. Most people only know the basics- Low-Density Lipoprotein (LDL) cholesterol is bad, and High-Density Lipoprotein (HDL) cholesterol is good. However, ...

My cholesterol has been on the rise for the past few years – and not just a slow creep. For most of my life, my LDL (often referred to as ‘bad’ cholesterol) was solidly under 120 mg/dl. Over the past ...

Lipid-laden macrophages are a defining pathological feature across a broad range of inflammatory diseases, including atherosclerosis, metabolic disorders, and chronic tissue injury, yet effective ...

Please provide your email address to receive an email when new articles are posted on . ApoA-I infusions may improve outcomes after acute heart attack for patients with multivessel CAD and ...

Some of the changes that occur during the menopausal transition can affect your cholesterol levels. These include decreased estrogen, loss of muscle mass, weight gain, and insulin resistance.

A 4-week trial on 'Navelina' oranges shows potential effects on lipid metabolism in fatty liver disease, revealing intriguing ...

Lipid research investigates the structure, function and metabolism of fats, covering their roles in industrial processes, the environment and health. Emerging research areas include nutrient ...